Agilysys (AGYS) Financials

$101.37 +18.35 (+22.10%)

As of 05/20/2025 04:00 PM Eastern

Annual Income Statements for Agilysys

This table shows Agilysys' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017	3/31/2016	3/31/2015	3/31/2014
Net Income / (Loss) Attributable to Common Shareholders	85	13	4.64	-24	-34	-13	-8.05	-12	-3.77	-11	20
Consolidated Net Income / (Loss)	86	15	6.48	-21	-34	-13	-8.35	-12	-3.77	-11	17
Net Income / (Loss) Continuing Operations	86	15	6.48	-21	-34	-13	-8.05	-12	-3.77	-11	-2.90
Total Pre-Tax Income	21	16	6.51	-21	-34	-13	-12	-11	-3.76	-13	-5.39
Total Operating Income	16	13	6.32	-21	-34	-13	-12	-11	-4.31	-12	-6.19
Total Gross Profit	144	121	102	89	81	74	64	64	68	60	64
Total Revenue	237	198	163	137	161	141	127	128	120	104	101
Operating Revenue	237	198	163	137	161	141	127	128	120	104	101
Total Cost of Revenue	93	77	61	48	80	67	63	64	52	43	37
Operating Cost of Revenue	93	77	61	48	80	67	63	64	52	43	37
Total Operating Expenses	129	108	95	110	115	87	76	75	72	73	67
Selling, General & Admin Expense	38	31	29	36	24	23	24	20	22	22	21
Marketing Expense	28	23	15	14	20	20	18	21	20	16	14
Research & Development Expense	57	50	46	55	41	38	28	29	27	25	25
Depreciation Expense	3.90	1.77	2.21	2.83	2.57	2.50	2.63	2.41	2.20	2.23	2.07
Amortization Expense	1.37	1.74	1.65	1.96	2.54	2.57	1.88	1.39	1.24	3.46	6.41
Other Special Charges / (Income)	0.03	0.35	0.97	0.20	-0.13	0.14	0.15	0.09	0.45	1.69	1.39
Total Other Income / (Expense), net	4.93	2.89	0.19	-0.25	0.20	0.14	0.48	-0.08	0.55	-0.08	0.80
Interest Expense	0.00	0.00	0.01	0.02	0.01	0.01	0.01	0.02	0.03	0.05	0.18
Interest & Investment Income	5.08	2.19	0.06	0.11	0.38	0.34	0.10	0.16	0.09	0.11	0.12
Other Income / (Expense), net	-0.15	0.70	0.15	-0.34	-0.18	-0.19	0.39	-0.22	0.49	-0.15	0.86
Income Tax Expense	-66	1.18	0.03	-0.21	0.20	0.22	-3.25	0.24	0.01	-1.05	-2.49
Preferred Stock Dividends Declared	1.20	1.84	1.84	2.61	0.00	0.00	-	-	-	-	-
Basic Earnings per Share	$3.31	$0.52	$0.19	($1.01)	($1.47)	($0.57)	($0.37)	($0.52)	($0.17)	($0.51)	$0.77
Weighted Average Basic Shares Outstanding	25.67M	24.69M	24.36M	23.46M	23.23M	23.04M	22.80M	22.62M	22.48M	22.34M	22.14M
Diluted Earnings per Share	$3.17	$0.49	$0.18	($1.01)	($1.47)	($0.57)	($0.37)	($0.52)	($0.17)	($0.51)	$0.77
Weighted Average Diluted Shares Outstanding	26.84M	25.93M	25.48M	23.46M	23.23M	23.04M	22.80M	22.62M	22.48M	22.34M	22.14M
Weighted Average Basic & Diluted Shares Outstanding	27.45M	25.34M	24.74M	23.89M	23.40M	23.04M	22.80M	22.62M	22.48M	22.34M	22.14M

This table shows Agilysys' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2022	12/31/2021
Net Income / (Loss) Attributable to Common Shareholders	3.83	1.36	14	77	4.09	1.09	-2.14	1.08
Consolidated Net Income / (Loss)	3.83	1.36	14	77	4.55	1.55	-1.68	1.54
Net Income / (Loss) Continuing Operations	3.83	1.36	14	77	4.55	1.55	-1.68	1.54
Total Pre-Tax Income	7.74	5.15	7.37	9.10	4.84	1.90	-1.91	1.57
Total Operating Income	7.41	4.13	5.75	7.75	3.56	0.96	-1.25	1.61
Total Gross Profit	44	43	40	38	35	33	19	25
Total Revenue	70	68	64	61	59	56	28	39
Operating Revenue	70	68	64	61	59	56	28	39
Total Cost of Revenue	26	25	24	23	24	23	8.97	15
Operating Cost of Revenue	26	25	24	23	24	23	8.97	15
Total Operating Expenses	36	39	34	30	32	32	20	23
Selling, General & Admin Expense	9.54	12	11	9.06	9.00	10	6.93	7.19
Marketing Expense	9.01	8.79	7.01	6.14	6.40	7.30	0.05	3.94
Research & Development Expense	15	16	15	15	15	13	11	11
Depreciation Expense	0.99	0.92	0.84	0.91	1.21	0.92	0.78	0.50
Amortization Expense	1.62	0.90	0.25	0.34	0.35	0.43	0.49	0.27
Other Operating Expenses / (Income)	-0.01	-	-	-0.92	-	-	-	-
Other Special Charges / (Income)	0.33	0.10	0.27	0.00	0.00	0.00	-	0.00
Total Other Income / (Expense), net	0.33	1.02	1.63	1.35	1.28	0.94	-0.66	-0.05
Interest Expense	0.66	0.46	0.00	0.00	0.00	0.00	0.01	0.00
Interest & Investment Income	0.42	1.10	1.78	1.25	1.23	1.10	-0.43	0.01
Other Income / (Expense), net	0.57	0.38	-0.16	0.10	0.05	-0.16	-0.22	-0.05
Income Tax Expense	3.91	3.78	-6.73	-68	0.30	0.35	-0.23	0.02
Preferred Stock Dividends Declared	0.00	0.00	0.00	0.29	0.46	0.46	0.46	0.46
Basic Earnings per Share	$0.14	$0.05	$0.52	$2.98	$0.16	$0.04	($0.08)	$0.04
Weighted Average Basic Shares Outstanding	27.67M	27.53M	27.13M	25.81M	25.02M	24.94M	24.36M	24.48M
Diluted Earnings per Share	$0.14	$0.05	$0.50	$2.85	$0.16	$0.04	($0.08)	$0.04
Weighted Average Diluted Shares Outstanding	28.31M	28.26M	28.13M	26.98M	26.12M	26.18M	25.48M	25.39M
Weighted Average Basic & Diluted Shares Outstanding	27.96M	27.95M	27.88M	-	25.37M	25.35M	24.74M	25.21M

This table details how cash moves in and out of Agilysys' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017	3/31/2016	3/31/2015	3/31/2014
Net Change in Cash & Equivalents	32	16	-2.21	53	5.88	0.94	-9.51	-11	-14	-24	17
Net Cash From Operating Activities	48	34	28	28	11	7.24	6.87	3.43	7.22	-2.19	0.07
Net Cash From Continuing Operating Activities	48	34	28	28	11	7.24	6.87	3.43	7.22	-2.19	1.38
Net Income / (Loss) Continuing Operations	86	15	6.48	-21	-34	-13	-8.35	-12	-3.77	-11	-2.90
Consolidated Net Income / (Loss)	86	15	6.48	-21	-34	-13	-8.35	-12	-3.77	-11	17
Depreciation Expense	3.90	1.77	2.21	2.83	2.57	2.50	2.63	2.41	2.20	2.23	2.07
Amortization Expense	1.37	1.74	1.65	1.96	15	15	12	9.40	2.27	4.76	6.73
Non-Cash Adjustments To Reconcile Net Income	13	13	15	40	29	4.39	4.69	2.17	3.73	5.20	1.95
Changes in Operating Assets and Liabilities, net	-56	3.35	3.39	4.48	-1.97	-1.66	-3.99	1.17	2.79	-2.87	-6.47
Net Cash From Investing Activities	-7.60	-6.87	-26	-1.39	-3.45	-5.53	-15	-14	-21	-22	18
Net Cash From Continuing Investing Activities	-7.60	-6.87	-26	-1.39	-3.45	-5.53	-15	-14	-21	-22	18
Purchase of Property, Plant & Equipment	-8.13	-7.24	-1.20	-1.39	-3.42	-	-6.14	-4.16	-5.90	-4.65	-4.02
Acquisitions	0.00	0.40	-24	0.00	0.00	-	-	0.00	-	-3.75	-1.81
Sale of Property, Plant & Equipment	0.55	0.00	0.00	-	-	3.32	-	-	-	-	-
Other Investing Activities, net	-0.03	-0.03	-0.03	-0.00	-0.03	2.22	-8.95	-9.71	-15	-14	-12
Net Cash From Financing Activities	-8.56	-11	-4.90	25	-1.12	-0.77	-1.30	-0.45	-0.58	-0.40	-0.96
Net Cash From Continuing Financing Activities	-8.56	-11	-4.90	25	-1.12	-0.77	-1.30	-0.85	-0.58	-0.40	-0.88
Repayment of Debt	-0.00	-0.00	-0.02	-0.02	-0.02	-0.12	-0.12	-0.12	-0.14	-0.14	-0.18
Payment of Dividends	-1.66	-1.84	-1.84	-1.12	0.00	0.00	-	-	-	-	-
Other Financing Activities, net	-6.89	-9.25	-3.05	-7.51	-1.09	-0.65	-1.17	-0.73	-0.44	-0.26	-0.71
Effect of Exchange Rate Changes	0.02	-	-0.10	0.20	-0.13	-	-	-0.07	-0.09	-0.28	-0.04

This table details how cash moves in and out of Agilysys' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2022	12/31/2022
Net Change in Cash & Equivalents	5.87	-89	-0.78	8.79	0.32	-5.75	-11	9.62
Net Cash From Operating Activities	20	6.59	1.10	13	5.45	0.02	11	15
Net Cash From Continuing Operating Activities	20	6.59	1.10	13	5.45	0.02	11	15
Net Income / (Loss) Continuing Operations	3.83	1.36	14	77	4.55	1.55	-4.03	3.89
Consolidated Net Income / (Loss)	3.83	1.36	14	77	4.55	1.55	-4.03	3.89
Depreciation Expense	0.99	0.91	0.84	0.91	1.21	0.92	0.84	0.44
Amortization Expense	1.62	0.90	0.25	0.34	0.35	0.43	0.33	0.43
Non-Cash Adjustments To Reconcile Net Income	4.22	4.03	4.43	2.49	2.68	3.17	5.33	3.47
Changes in Operating Assets and Liabilities, net	9.63	-0.62	-19	-68	-3.34	-6.05	8.32	6.34
Net Cash From Investing Activities	-0.59	-146	-0.87	-1.66	-2.94	-3.07	-22	-2.84
Net Cash From Continuing Investing Activities	-0.59	-146	-0.87	-1.66	-2.94	-3.07	-22	-2.84
Purchase of Property, Plant & Equipment	-0.56	-0.65	-0.87	-1.66	-2.94	-3.07	2.42	-2.82
Other Investing Activities, net	-0.03	-	0.00	-	-	-0.00	-	-0.03
Net Cash From Financing Activities	-13	50	-0.93	-2.61	-2.09	-2.70	-0.14	-2.39
Net Cash From Continuing Financing Activities	-13	50	-0.93	-2.61	-2.09	-2.70	-0.14	-2.39
Repayment of Debt	-12	-	0.00	-	-0.00	-0.00	-0.02	-0.00
Issuance of Debt	-0.01	-	-	-	-	-	-	-
Other Financing Activities, net	-1.42	-0.50	-0.93	-1.87	-2.09	-1.78	-0.12	-1.47
Effect of Exchange Rate Changes	-0.40	0.18	-0.08	0.15	-0.11	-0.00	0.32	0.29

This table presents Agilysys' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017	3/31/2016	3/31/2015	3/31/2014
Total Assets	350	243	214	190	155	164	157	167	185	182	191
Total Current Assets	189	155	136	133	93	79	64	74	96	105	130
Cash & Equivalents	145	113	97	99	47	41	40	49	61	75	100
Accounts Receivable	29	22	25	26	36	27	16	16	22	25	24
Inventories, net	4.59	9.77	6.94	1.18	3.89	2.04	2.00	2.21	2.69	0.64	0.48
Prepaid Expenses	7.73	7.42	5.42	4.80	4.87	6.27	5.59	6.46	10	3.83	3.30
Other Current Assets	2.29	2.24	1.67	2.36	2.13	2.92	0.00	-	-	-	2.89
Plant, Property, & Equipment, net	18	15	6.35	8.79	12	16	18	16	15	12	12
Total Noncurrent Assets	144	74	72	48	49	69	76	78	74	65	49
Goodwill	33	33	33	20	20	20	20	20	20	20	17
Intangible Assets	17	18	20	8.40	8.40	43	54	56	52	41	28
Noncurrent Deferred & Refundable Income Taxes	67	2.79	2.66	1.80	0.76	0.44	-	-	-	-	-
Other Noncurrent Operating Assets	26	20	16	18	20	5.68	2.48	2.63	3.05	4.13	3.79
Total Liabilities & Shareholders' Equity	350	243	214	190	155	164	157	167	185	182	191
Total Liabilities	114	134	117	110	83	63	49	54	62	57	58
Total Current Liabilities	89	79	71	61	69	58	45	46	54	51	48
Accounts Payable	9.42	9.42	9.77	6.35	13	4.72	8.40	8.70	7.76	17	11
Accrued Expenses	20	14	11	11	9.03	14	9.24	8.33	13	10	14
Other Current Liabilities	60	55	51	43	47	39	27	-	-	-	-
Total Noncurrent Liabilities	25	55	45	49	13	5.15	4.20	7.30	7.58	6.73	9.88
Long-Term Debt	0.00	-	-	-	-	-	-	-	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	0.55	2.26	0.94	0.92	0.88	0.86	0.23	3.18	3.08	3.05	3.42
Other Noncurrent Operating Liabilities	24	53	44	48	12	4.26	3.91	4.00	4.29	3.63	6.17
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	236	109	97	80	72	101	108	114	123	124	133
Total Preferred & Common Equity	236	109	97	80	72	101	108	114	123	124	133
Preferred Stock	0.00	0.00	-	-	0.00	-	-	-	-	-	-
Total Common Equity	236	109	97	80	72	101	108	114	123	124	133
Common Stock	105	62	59	47	15	10	7.57	3.70	1.84	-1.19	-3.93
Retained Earnings	138	53	40	35	59	93	104	113	124	128	140
Treasury Stock	-1.79	-1.88	-2.06	-2.28	-2.40	-2.43	-2.49	-2.52	-2.60	-2.65	-2.74
Accumulated Other Comprehensive Income / (Loss)	-4.17	-4.03	-0.06	0.04	0.20	-0.26	-0.26	-0.20	-0.18	-0.15	-0.13

This table presents Agilysys' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q2 2023	Q1 2023	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	9/30/2023	6/30/2023	12/31/2022
Total Assets	444	442	356	255	251	246
Total Current Assets	131	109	187	153	149	159
Cash & Equivalents	61	55	144	107	107	106
Accounts Receivable	49	32	27	28	26	32
Inventories, net	6.36	6.45	5.30	7.49	8.45	10
Prepaid Expenses	11	11	6.52	7.47	6.03	8.43
Other Current Assets	4.02	4.54	3.52	3.28	2.28	2.53
Plant, Property, & Equipment, net	17	18	18	17	16	9.70
Total Noncurrent Assets	296	316	151	84	86	77
Goodwill	129	135	33	33	33	34
Intangible Assets	74	79	17	18	18	19
Noncurrent Deferred & Refundable Income Taxes	68	75	76	3.15	2.93	2.38
Other Noncurrent Operating Assets	26	26	26	31	32	22
Total Liabilities & Shareholders' Equity	444	442	356	255	251	246
Total Liabilities	187	182	102	139	140	134
Total Current Liabilities	115	96	77	73	74	81
Accounts Payable	12	13	10	10	11	9.75
Accrued Expenses	17	22	13	14	11	12
Other Current Liabilities	86	61	54	49	52	60
Total Noncurrent Liabilities	72	86	24	66	66	53
Long-Term Debt	38	50	-	-	-	-
Noncurrent Deferred & Payable Income Tax Liabilities	12	12	0.55	2.28	2.30	1.68
Other Noncurrent Operating Liabilities	23	24	24	64	63	51
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	257	260	254	117	112	112
Total Preferred & Common Equity	257	260	254	117	112	112
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	257	260	254	117	112	112
Common Stock	115	112	108	65	63	66
Retained Earnings	157	153	152	58	54	49
Treasury Stock	-1.62	-1.62	-1.64	-1.87	-1.88	-1.93
Accumulated Other Comprehensive Income / (Loss)	-14	-3.62	-4.33	-4.09	-3.51	-0.96

This table displays calculated financial ratios and metrics derived from Agilysys' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017	3/31/2016	3/31/2015	3/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.89%	21.78%	18.56%	-14.67%	14.14%	10.59%	-0.25%	6.07%	16.28%	2.22%	7.72%
EBITDA Growth	22.12%	65.41%	162.58%	0.34%	-476.30%	55.13%	1,467.40%	-71.81%	111.40%	-262.10%	216.89%
EBIT Growth	14.95%	109.96%	130.35%	37.80%	-157.96%	-13.54%	-0.49%	-204.34%	69.70%	-136.86%	42.11%
NOPAT Growth	451.20%	89.43%	142.85%	38.47%	-160.39%	-8.29%	-5.89%	-164.50%	65.40%	-101.47%	33.51%
Net Income Growth	491.11%	125.10%	130.85%	38.35%	-158.79%	-57.65%	28.76%	-211.31%	67.25%	-167.25%	1,417.18%
EPS Growth	546.94%	172.22%	117.82%	31.29%	-157.89%	-54.05%	28.85%	-205.88%	66.67%	-166.23%	1,383.33%
Operating Cash Flow Growth	39.82%	21.03%	0.24%	168.62%	46.04%	5.34%	100.23%	-52.44%	430.19%	-3,094.52%	100.56%
Free Cash Flow Firm Growth	-286.33%	218.16%	-144.99%	172.64%	2,989.67%	96.97%	-31.81%	43.97%	30.78%	-31.21%	-130.94%
Invested Capital Growth	2,693.04%	-1,041.87%	101.94%	-176.80%	-58.04%	-12.79%	6.21%	2.33%	28.12%	46.57%	73.58%
Revenue Q/Q Growth	0.00%	0.00%	-4.91%	-2.37%	13.16%	-7.30%	1.16%	-1.03%	2.75%	0.93%	9.23%
EBITDA Q/Q Growth	0.00%	0.00%	169.58%	19.79%	-344.70%	-17.85%	385.41%	-90.51%	118.84%	-563,200.00%	168.13%
EBIT Q/Q Growth	0.00%	0.00%	138.28%	9.53%	-216.16%	-13.76%	21.89%	-50.05%	52.68%	-43.04%	6.45%
NOPAT Q/Q Growth	0.00%	0.00%	152.21%	9.37%	-213.03%	-13.08%	19.87%	-40.10%	45.81%	-32.68%	0.48%
Net Income Q/Q Growth	0.00%	0.00%	140.18%	11.43%	-219.46%	-34.53%	37.81%	-47.05%	50.81%	-42.31%	-12.03%
EPS Q/Q Growth	0.00%	0.00%	122.78%	9.82%	-219.57%	-29.55%	36.21%	-44.44%	0.00%	0.00%	-11.49%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-12.37%	50.33%	-2.04%	11.49%	4,881.16%	-70.74%	33.39%	-216.59%	101.75%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	53.77%	-40.12%	141.50%	91.67%	22.39%	22.55%	-79.30%	-3.15%	-131.98%
Invested Capital Q/Q Growth	0.00%	0.00%	-93.85%	-78.37%	-54.36%	-10.88%	-2.96%	-0.92%	7.56%	-10.16%	-11.04%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	60.75%	61.00%	62.43%	65.15%	50.36%	52.46%	50.58%	49.96%	56.58%	58.04%	63.24%
EBITDA Margin	8.79%	8.63%	6.35%	-12.03%	-10.30%	3.12%	2.23%	0.14%	0.53%	-5.44%	3.43%
Operating Margin	6.63%	6.50%	3.89%	-15.28%	-21.19%	-9.29%	-9.48%	-8.94%	-3.58%	-12.04%	-6.11%
EBIT Margin	6.57%	6.85%	3.97%	-15.52%	-21.30%	-9.42%	-9.18%	-9.11%	-3.18%	-12.18%	-5.26%
Profit (Net Income) Margin	36.30%	7.36%	3.98%	-15.31%	-21.19%	-9.35%	-6.56%	-9.18%	-3.13%	-11.11%	16.88%
Tax Burden Percent	416.72%	92.50%	99.49%	99.02%	100.59%	101.71%	71.98%	102.05%	100.16%	91.60%	-317.43%
Interest Burden Percent	132.58%	116.15%	100.73%	99.59%	98.92%	97.52%	99.25%	98.74%	98.35%	99.51%	101.15%
Effective Tax Rate	-316.72%	7.50%	0.51%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	149.10%	0.00%	0.00%	-503.19%	-56.09%	-14.25%	-12.69%	-12.49%	-5.37%	-21.04%	-16.34%
ROIC Less NNEP Spread (ROIC-NNEP)	133.16%	0.00%	0.00%	-494.51%	-32.68%	-4.29%	-12.92%	-5.66%	-4.26%	-17.86%	-38.46%
Return on Net Nonoperating Assets (RNNOA)	-99.25%	0.00%	0.00%	475.49%	16.56%	1.65%	5.17%	2.61%	2.33%	12.10%	30.20%
Return on Equity (ROE)	49.85%	14.11%	7.31%	-27.70%	-39.53%	-12.59%	-7.52%	-9.89%	-3.04%	-8.95%	13.86%
Cash Return on Invested Capital (CROIC)	-32.18%	0.00%	-3,569.61%	0.00%	25.68%	-0.59%	-18.71%	-14.80%	-30.02%	-58.82%	-70.13%
Operating Return on Assets (OROA)	5.26%	5.94%	3.20%	-12.37%	-21.52%	-8.27%	-7.20%	-6.60%	-2.08%	-6.77%	-2.74%
Return on Assets (ROA)	29.05%	6.38%	3.21%	-12.19%	-21.42%	-8.21%	-5.15%	-6.65%	-2.05%	-6.17%	8.80%
Return on Common Equity (ROCE)	49.85%	14.11%	7.31%	-27.70%	-39.53%	-12.59%	-7.52%	-9.89%	-3.04%	-8.95%	13.86%
Return on Equity Simple (ROE_SIMPLE)	36.45%	13.34%	6.65%	-26.29%	-47.48%	-13.08%	-7.70%	-10.31%	-3.05%	-9.26%	12.87%
Net Operating Profit after Tax (NOPAT)	66	12	6.29	-15	-24	-9.16	-8.46	-7.99	-3.02	-8.73	-4.33
NOPAT Margin	27.64%	6.01%	3.87%	-10.69%	-14.83%	-6.50%	-6.64%	-6.25%	-2.51%	-8.43%	-4.28%
Net Nonoperating Expense Percent (NNEP)	15.95%	2.55%	0.19%	-8.68%	-23.41%	-9.96%	0.24%	-6.83%	-1.10%	-3.18%	22.12%
Cost of Revenue to Revenue	39.25%	39.00%	37.57%	34.85%	49.64%	47.54%	49.42%	50.04%	43.42%	41.96%	36.76%
SG&A Expenses to Revenue	16.02%	15.70%	18.03%	26.10%	15.16%	16.41%	18.87%	15.57%	18.13%	20.93%	20.49%
R&D to Revenue	23.89%	25.38%	28.49%	40.35%	25.79%	26.85%	21.93%	22.75%	22.17%	24.46%	24.90%
Operating Expenses to Revenue	54.11%	54.50%	58.54%	80.43%	71.54%	61.74%	59.83%	58.89%	60.17%	70.09%	66.60%
Earnings before Interest and Taxes (EBIT)	16	14	6.46	-21	-34	-13	-12	-12	-3.82	-13	-5.33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	21	17	10	-17	-17	4.40	2.84	0.18	0.64	-5.63	3.48
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	9.04	19.03	10.13	14.19	5.51	4.95	2.56	1.93	1.90	1.81	2.27
Price to Tangible Book Value (P/TBV)	11.45	35.54	22.19	21.86	9.03	13.11	7.91	5.70	4.50	3.52	3.43
Price to Revenue (P/Rev)	9.00	10.50	6.06	8.26	2.46	3.54	2.18	1.72	1.95	2.17	2.97
Price to Earnings (P/E)	25.16	163.19	212.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.15
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	3.98%	0.61%	0.47%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.60%
Enterprise Value to Invested Capital (EV/IC)	21.76	0.00	2,369.70	0.00	13.87	7.64	3.47	2.64	2.76	3.04	6.00
Enterprise Value to Revenue (EV/Rev)	8.39	9.93	5.46	7.54	2.17	3.25	1.87	1.34	1.45	1.45	2.00
Enterprise Value to EBITDA (EV/EBITDA)	95.53	115.14	86.04	0.00	0.00	103.95	83.94	941.95	271.48	0.00	58.13
Enterprise Value to EBIT (EV/EBIT)	127.75	144.94	137.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	30.36	165.17	141.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	41.36	57.08	31.21	36.42	32.95	63.18	34.64	49.66	24.15	0.00	2,767.29
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	124.37	0.00	34.77	31.93	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.75	-1.02	-1.11	-0.96	-0.51	-0.39	-0.40	-0.46	-0.55	-0.68	-0.79
Leverage Ratio	1.72	2.21	2.28	2.27	1.85	1.53	1.46	1.49	1.48	1.45	1.57
Compound Leverage Factor	2.28	2.57	2.30	2.26	1.83	1.50	1.45	1.47	1.46	1.44	1.59
Debt to Total Capital	0.00%	0.00%	0.00%	0.01%	0.03%	0.03%	0.16%	0.21%	0.27%	0.15%	0.25%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.11%	0.11%	0.10%	0.11%	0.03%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.01%	0.03%	0.03%	0.05%	0.10%	0.17%	0.04%	0.22%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	99.99%	99.97%	99.97%	99.84%	99.79%	99.73%	99.85%	99.75%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.01	0.06	1.31	0.52	-0.03	0.10
Net Debt to EBITDA	0.00	0.00	-9.39	6.01	2.82	-9.26	-14.02	-270.82	-93.89	13.29	-28.56
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.01	0.02	0.64	0.33	-0.01	0.08
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	-0.03	-0.11	-0.02	-0.08
Net Debt to NOPAT	0.00	0.00	-15.42	6.76	1.96	4.45	4.70	6.14	19.96	8.58	22.91
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-0.01	-0.01	-0.07	-0.01	-0.07
Altman Z-Score	12.97	11.01	6.55	7.25	3.89	6.29	5.05	4.13	4.07	4.04	5.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.11	1.97	1.91	2.18	1.35	1.37	1.43	1.59	1.77	2.08	2.70
Quick Ratio	1.95	1.72	1.71	2.04	1.19	1.17	1.26	1.40	1.53	1.99	2.56
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-29	16	-13	30	11	-0.38	-12	-9.46	-17	-24	-19
Operating Cash Flow to CapEx	636.12%	476.14%	2,378.86%	2,045.14%	309.21%	0.00%	111.95%	82.56%	122.34%	-47.01%	1.81%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-1,115.50	1,487.82	1,212.70	-37.77	-1,247.00	-630.71	-582.24	-508.23	-101.05
Operating Cash Flow to Interest Expense	0.00	0.00	2,372.92	1,420.35	1,175.00	724.10	687.40	228.87	248.90	-45.54	0.40
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	2,273.17	1,350.90	795.00	1,055.90	73.40	-48.33	45.45	-142.42	-21.47
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.80	0.87	0.81	0.80	1.01	0.88	0.78	0.72	0.66	0.56	0.52
Accounts Receivable Turnover	9.17	8.33	6.39	4.45	5.11	6.49	7.96	6.79	5.07	4.22	5.17
Inventory Turnover	12.98	9.24	15.06	18.88	26.91	33.12	29.90	26.06	31.36	77.42	57.71
Fixed Asset Turnover	14.61	18.93	21.49	13.05	11.45	8.45	7.60	8.17	8.86	8.56	7.78
Accounts Payable Turnover	9.89	8.05	7.58	4.84	8.81	10.21	7.36	7.76	4.29	3.14	3.56
Days Sales Outstanding (DSO)	39.82	43.82	57.12	81.95	71.37	56.22	45.84	53.77	72.02	86.56	70.66
Days Inventory Outstanding (DIO)	28.12	39.49	24.24	19.33	13.56	11.02	12.21	14.00	11.64	4.71	6.33
Days Payable Outstanding (DPO)	36.89	45.32	48.12	75.40	41.44	35.75	49.59	47.02	85.02	116.22	102.64
Cash Conversion Cycle (CCC)	31.06	37.98	33.25	25.89	43.50	31.49	8.46	20.75	-1.37	-24.95	-25.65
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	92	-3.53	0.38	-19	25	60	69	65	63	49	34
Invested Capital Turnover	5.39	-125.48	-17.19	47.05	3.78	2.19	1.91	2.00	2.14	2.50	3.82
Increase / (Decrease) in Invested Capital	95	-3.91	20	-44	-35	-8.78	4.01	1.48	14	16	14
Enterprise Value (EV)	1,993	1,967	889	1,034	348	458	238	170	174	150	202
Market Capitalization	2,138	2,080	986	1,134	395	498	278	220	235	225	301
Book Value per Share	$9.21	$4.34	$3.94	$3.38	$3.03	$4.28	$4.65	$4.89	$5.37	$5.44	$5.91
Tangible Book Value per Share	$7.28	$2.32	$1.80	$2.19	$1.85	$1.61	$1.51	$1.66	$2.27	$2.79	$3.91
Total Capital	236	109	97	80	72	101	109	114	124	124	133
Total Debt	0.00	0.00	0.00	0.01	0.03	0.04	0.18	0.24	0.33	0.19	0.34
Total Long-Term Debt	0.00	0.00	0.00	0.01	0.03	0.04	0.06	0.12	0.22	0.05	0.29
Net Debt	-145	-113	-97	-99	-47	-41	-40	-49	-60	-75	-99
Capital Expenditures (CapEx)	7.58	7.24	1.20	1.39	3.42	-3.32	6.14	4.16	5.90	4.65	4.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-45	-37	-32	-27	-23	-20	-20	-22	-19	-21	-18
Debt-free Net Working Capital (DFNWC)	100	76	65	72	24	21	19	27	42	55	82
Net Working Capital (NWC)	100	76	65	72	24	21	19	27	41	54	82
Net Nonoperating Expense (NNE)	-21	-2.67	-0.19	6.33	10	4.01	-0.11	3.74	0.75	2.77	-21
Net Nonoperating Obligations (NNO)	-145	-113	-97	-99	-47	-41	-40	-49	-60	-75	-99
Total Depreciation and Amortization (D&A)	5.26	3.51	3.86	4.79	18	18	15	12	4.46	6.98	8.80
Debt-free, Cash-free Net Working Capital to Revenue	-19.09%	-18.53%	-19.84%	-19.74%	-14.10%	-13.90%	-16.08%	-17.19%	-15.86%	-19.82%	-17.59%
Debt-free Net Working Capital to Revenue	41.93%	38.44%	39.79%	52.56%	14.92%	15.05%	15.28%	21.39%	34.49%	52.70%	80.74%
Net Working Capital to Revenue	41.93%	38.44%	39.79%	52.56%	14.92%	15.05%	15.19%	21.29%	34.40%	52.56%	80.69%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.31	$0.52	$0.19	($1.01)	($1.47)	($0.57)	($0.37)	($0.52)	($0.17)	($0.51)	$0.77
Adjusted Weighted Average Basic Shares Outstanding	25.67M	24.69M	24.36M	23.46M	23.23M	23.50M	23.23M	23.21M	22.94M	22.77M	22.47M
Adjusted Diluted Earnings per Share	$3.17	$0.49	$0.18	($1.01)	($1.47)	($0.57)	($0.37)	($0.52)	($0.17)	($0.51)	$0.77
Adjusted Weighted Average Diluted Shares Outstanding	26.84M	25.93M	25.48M	23.89M	23.40M	23.50M	23.23M	23.21M	22.94M	22.77M	22.47M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	($1.01)	($1.47)	($0.57)	($0.37)	($0.52)	($0.17)	($0.51)	$0.77
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.45M	25.34M	24.74M	23.89M	23.40M	23.04M	22.80M	22.62M	22.48M	22.34M	22.14M
Normalized Net Operating Profit after Tax (NOPAT)	11	12	7.25	-15	-7.31	-9.06	-7.09	-6.83	-2.51	-6.26	-3.13
Normalized NOPAT Margin	4.65%	6.18%	4.46%	-10.59%	-4.55%	-6.43%	-5.57%	-5.35%	-2.08%	-6.05%	-3.09%
Pre Tax Income Margin	8.71%	7.96%	4.00%	-15.46%	-21.07%	-9.19%	-9.11%	-9.00%	-3.12%	-12.12%	-5.32%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	538.67	-1,064.80	-3,804.11	-1,327.20	-1,168.90	-775.47	-131.79	-262.77	-28.94
NOPAT to Interest Expense	0.00	0.00	523.91	-733.53	-2,649.19	-915.67	-845.60	-532.37	-104.11	-181.81	-23.54
EBIT Less CapEx to Interest Expense	0.00	0.00	438.92	-1,134.25	-4,184.11	-995.40	-1,782.90	-1,052.67	-335.24	-359.65	-50.80
NOPAT Less CapEx to Interest Expense	0.00	0.00	424.16	-802.98	-3,029.19	-583.87	-1,459.60	-809.57	-307.56	-278.69	-45.41
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	1.93%	12.59%	28.34%	-5.32%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	1.93%	12.59%	28.34%	-5.32%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Agilysys' official financial filings.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2022	12/31/2021
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	14.85%	16.49%	13.29%	53.49%	22.78%	18.00%	-23.14%	7.59%
EBITDA Growth	16.41%	22.40%	210.36%	274.91%	31.09%	-49.52%	98.74%	304.98%
EBIT Growth	1.76%	24.80%	599.62%	402.95%	18.89%	-76.06%	94.07%	181.85%
NOPAT Growth	-94.42%	-67.30%	1,308.89%	4,040.37%	9.23%	-70.90%	94.94%	225.21%
Net Income Growth	-95.04%	-69.99%	811.24%	4,902.66%	27.10%	-49.06%	93.09%	174.49%
EPS Growth	-95.09%	-68.75%	1,150.00%	7,025.00%	33.33%	-60.00%	92.38%	136.36%
Operating Cash Flow Growth	57.16%	20.96%	4,890.91%	-11.36%	80.64%	-78.22%	-27.12%	83.88%
Free Cash Flow Firm Growth	-420.78%	-5,500.64%	-3,779.44%	568.58%	130.04%	137.04%	-175.87%	-123.72%
Invested Capital Growth	0.00%	2,674.30%	2,296.26%	0.00%	-11.47%	-28.01%	101.94%	156.33%
Revenue Q/Q Growth	1.88%	7.51%	0.00%	3.33%	4.56%	100.73%	-44.05%	-17.35%
EBITDA Q/Q Growth	67.41%	-5.27%	0.00%	76.03%	140.20%	805.57%	-106.46%	-38.45%
EBIT Q/Q Growth	77.07%	-19.34%	0.00%	117.16%	352.19%	154.28%	-138.08%	-48.67%
NOPAT Q/Q Growth	235.15%	-90.05%	0.00%	1,864.78%	328.55%	188.99%	-129.58%	-48.17%
Net Income Q/Q Growth	180.79%	-90.33%	0.00%	1,597.27%	193.60%	192.20%	-143.14%	-56.88%
EPS Q/Q Growth	180.00%	-90.00%	0.00%	1,681.25%	300.00%	150.00%	-161.54%	-66.67%
Operating Cash Flow Q/Q Growth	207.86%	500.18%	0.00%	136.95%	24,663.64%	-99.80%	-25.87%	382.86%
Free Cash Flow Firm Q/Q Growth	6.00%	-159.42%	0.00%	1,482.54%	76.74%	112.49%	-47.34%	-1.47%
Invested Capital Q/Q Growth	-8.36%	132.03%	0.00%	-100.00%	100.41%	1,124.80%	-93.85%	-41.39%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	63.05%	63.29%	62.77%	62.45%	59.87%	58.97%	67.87%	62.64%
EBITDA Margin	15.23%	9.27%	10.52%	15.02%	8.82%	3.84%	-1.09%	6.15%
Operating Margin	10.65%	6.04%	9.05%	12.80%	6.08%	1.71%	-4.49%	4.09%
EBIT Margin	11.48%	6.60%	8.80%	12.95%	6.16%	1.43%	-5.27%	3.95%
Profit (Net Income) Margin	5.51%	2.00%	22.21%	127.37%	7.75%	2.76%	-6.01%	3.91%
Tax Burden Percent	49.46%	26.51%	191.35%	847.89%	93.91%	81.47%	87.91%	98.47%
Interest Burden Percent	96.98%	114.13%	131.88%	115.96%	133.96%	237.80%	129.76%	100.38%
Effective Tax Rate	50.54%	73.49%	-91.35%	-747.89%	6.10%	18.53%	0.00%	1.53%
Return on Invested Capital (ROIC)	10.09%	2.61%	62.07%	0.00%	106.00%	43.44%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	8.65%	2.12%	59.60%	0.00%	104.82%	42.68%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-0.77%	-0.63%	-40.92%	0.00%	-95.61%	-40.48%	0.00%	0.00%
Return on Equity (ROE)	9.33%	1.97%	21.15%	0.00%	10.38%	2.96%	7.31%	-16.65%
Cash Return on Invested Capital (CROIC)	-237.37%	-170.76%	-144.60%	0.00%	58.53%	110.13%	-3,569.61%	-475.13%
Operating Return on Assets (OROA)	5.80%	4.08%	5.96%	0.00%	4.72%	1.06%	-4.24%	3.11%
Return on Assets (ROA)	2.78%	1.23%	15.04%	0.00%	5.93%	2.05%	-4.84%	3.07%
Return on Common Equity (ROCE)	9.33%	1.97%	21.15%	0.00%	10.38%	2.96%	7.31%	-16.65%
Return on Equity Simple (ROE_SIMPLE)	-19.22%	9.21%	10.68%	0.00%	5.11%	4.47%	0.00%	-14.41%
Net Operating Profit after Tax (NOPAT)	3.67	1.09	11	66	3.34	0.78	-0.88	1.59
NOPAT Margin	5.27%	1.60%	17.31%	108.51%	5.71%	1.39%	-3.14%	4.02%
Net Nonoperating Expense Percent (NNEP)	1.45%	0.48%	2.48%	0.00%	1.18%	0.76%	-0.82%	-0.05%
Return On Investment Capital (ROIC_SIMPLE)	1.24%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	36.95%	36.71%	37.23%	37.55%	40.13%	41.03%	32.13%	37.36%
SG&A Expenses to Revenue	13.71%	17.87%	17.37%	14.95%	15.35%	18.06%	24.81%	18.21%
R&D to Revenue	21.52%	23.69%	23.18%	24.03%	24.88%	23.76%	39.35%	28.41%
Operating Expenses to Revenue	52.39%	57.25%	53.72%	49.65%	53.80%	57.26%	72.36%	58.55%
Earnings before Interest and Taxes (EBIT)	7.98	4.51	5.59	7.85	3.61	0.80	-1.47	1.56
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	11	6.33	6.68	9.10	5.17	2.15	-0.31	2.43
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	14.34	11.67	11.25	0.00	14.38	15.57	10.13	9.78
Price to Tangible Book Value (P/TBV)	67.29	66.31	13.96	0.00	25.28	28.64	22.19	18.49
Price to Revenue (P/Rev)	16.42	14.12	13.91	10.59	9.21	10.16	6.06	6.40
Price to Earnings (P/E)	0.00	131.86	110.98	26.94	407.14	551.91	212.32	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.76%	0.90%	3.71%	0.25%	0.18%	0.47%	0.00%
Enterprise Value to Invested Capital (EV/IC)	15.63	11.88	24.67	0.00	170.56	355.32	2,369.70	162.19
Enterprise Value to Revenue (EV/Rev)	16.32	14.10	13.21	0.00	8.62	9.53	5.46	5.78
Enterprise Value to EBITDA (EV/EBITDA)	150.80	133.22	125.63	0.00	166.26	198.61	86.04	0.00
Enterprise Value to EBIT (EV/EBIT)	188.62	157.51	147.85	0.00	348.89	415.68	137.48	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	149.63	120.26	0.00	345.56	383.54	141.35	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	83.04	82.70	76.39	0.00	50.93	57.47	31.21	30.42
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	273.69	270.10	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.15	0.19	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.15	0.19	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.09	-0.30	-0.69	0.00	-0.91	-0.95	-1.11	-1.02
Leverage Ratio	1.73	1.85	1.66	0.00	2.13	2.16	2.28	2.25
Compound Leverage Factor	1.68	2.11	2.19	0.00	2.86	5.14	2.96	2.26
Debt to Total Capital	12.89%	16.12%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	12.89%	16.12%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	87.11%	83.88%	100.00%	0.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	1.57	2.20	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-0.94	-0.21	0.00	0.00	0.00	0.00	-9.39	0.00
Long-Term Debt to EBITDA	1.57	2.20	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	-0.87	2.47	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.52	-0.24	0.00	0.00	0.00	0.00	-15.42	0.00
Long-Term Debt to NOPAT	-0.87	2.47	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	12.91	11.07	18.49	0.00	8.72	8.82	6.42	6.27
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	1.14	1.13	2.41	0.00	2.11	2.02	1.91	1.96
Quick Ratio	0.96	0.90	2.21	0.00	1.86	1.80	1.71	1.70
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-230	-245	-94	72	4.54	2.57	-21	-15
Operating Cash Flow to CapEx	3,609.96%	1,012.29%	126.35%	779.53%	185.50%	0.72%	0.00%	516.60%
Free Cash Flow to Firm to Interest Expense	-350.63	-535.10	0.00	0.00	0.00	0.00	-2,055.01	-3,831.43
Operating Cash Flow to Interest Expense	30.88	14.39	0.00	0.00	0.00	0.00	1,079.50	3,640.75
Operating Cash Flow Less CapEx to Interest Expense	30.02	12.97	0.00	0.00	0.00	0.00	1,321.40	2,936.00
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.51	0.62	0.68	0.00	0.77	0.74	0.81	0.79
Accounts Receivable Turnover	4.55	7.25	7.77	0.00	7.46	7.06	6.39	5.44
Inventory Turnover	12.96	11.40	11.33	0.00	8.19	8.29	15.06	11.14
Fixed Asset Turnover	13.29	12.29	12.22	0.00	15.32	15.65	21.49	17.80
Accounts Payable Turnover	7.05	6.96	7.55	0.00	6.85	6.95	7.58	8.56
Days Sales Outstanding (DSO)	80.23	50.36	46.97	0.00	48.91	51.69	57.12	67.11
Days Inventory Outstanding (DIO)	28.17	32.01	32.22	0.00	44.55	44.01	24.24	32.77
Days Payable Outstanding (DPO)	51.76	52.42	48.34	0.00	53.26	52.51	48.12	42.65
Cash Conversion Cycle (CCC)	56.64	29.95	30.85	0.00	40.20	43.19	33.25	57.23
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	234	255	110	0.00	9.21	4.59	0.38	6.09
Invested Capital Turnover	1.92	1.63	3.59	0.00	18.58	31.20	-17.19	-72.40
Increase / (Decrease) in Invested Capital	234	246	105	-6.09	-1.19	-1.79	20	17
Enterprise Value (EV)	3,659	3,033	2,715	0.00	1,570	1,632	889	988
Market Capitalization	3,681	3,038	2,859	2,152	1,677	1,739	986	1,094
Book Value per Share	$9.19	$9.33	$9.26	$0.00	$4.60	$4.41	$3.94	$4.55
Tangible Book Value per Share	$1.96	$1.64	$7.46	$0.00	$2.62	$2.40	$1.80	$2.40
Total Capital	295	310	254	0.00	117	112	97	112
Total Debt	38	50	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	38	50	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-23	-4.89	-144	0.00	-107	-107	-97	-106
Capital Expenditures (CapEx)	0.56	0.65	0.87	1.66	2.94	3.07	-2.42	2.82
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-45	-42	-35	0.00	-27	-32	-32	-28
Debt-free Net Working Capital (DFNWC)	16	13	109	0.00	81	76	65	78
Net Working Capital (NWC)	16	13	109	0.00	81	76	65	78
Net Nonoperating Expense (NNE)	-0.16	-0.27	-3.11	-11	-1.20	-0.77	0.80	0.05
Net Nonoperating Obligations (NNO)	-23	-4.89	-144	0.00	-107	-107	-97	-106
Total Depreciation and Amortization (D&A)	2.61	1.82	1.09	1.25	1.56	1.35	1.17	0.87
Debt-free, Cash-free Net Working Capital to Revenue	-19.85%	-19.55%	-16.91%	0.00%	-14.67%	-18.43%	-19.84%	-16.29%
Debt-free Net Working Capital to Revenue	7.25%	5.95%	53.21%	0.00%	44.33%	44.13%	39.79%	45.57%
Net Working Capital to Revenue	7.25%	5.95%	53.21%	0.00%	44.33%	44.13%	39.79%	45.57%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.14	$0.05	$0.52	$0.00	$0.16	$0.04	($0.08)	$0.04
Adjusted Weighted Average Basic Shares Outstanding	27.67M	27.53M	27.13M	0.00	25.02M	24.94M	24.36M	24.48M
Adjusted Diluted Earnings per Share	$0.14	$0.05	$0.50	$0.00	$0.16	$0.04	($0.08)	$0.04
Adjusted Weighted Average Diluted Shares Outstanding	28.31M	28.26M	28.13M	0.00	26.12M	26.18M	25.48M	25.39M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.96M	27.95M	27.88M	0.00	25.37M	25.35M	24.74M	25.21M
Normalized Net Operating Profit after Tax (NOPAT)	5.42	2.96	4.21	5.43	3.34	0.78	-0.88	1.59
Normalized NOPAT Margin	7.79%	4.34%	6.63%	8.96%	5.71%	1.39%	-3.14%	4.03%
Pre Tax Income Margin	11.13%	7.54%	11.61%	15.02%	8.26%	3.39%	-6.84%	3.97%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	12.15	9.85	0.00	0.00	0.00	0.00	-147.20	390.00
NOPAT to Interest Expense	5.58	2.39	0.00	0.00	0.00	0.00	-87.71	396.82
EBIT Less CapEx to Interest Expense	11.30	8.42	0.00	0.00	0.00	0.00	94.70	-314.75
NOPAT Less CapEx to Interest Expense	4.72	0.97	0.00	0.00	0.00	0.00	154.19	-307.93
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-0.35%	3.83%	3.38%	2.04%	30.83%	36.82%	28.34%	-25.24%
Augmented Payout Ratio	-0.35%	3.83%	3.38%	2.04%	30.83%	36.82%	28.34%	-25.24%

Frequently Asked Questions About Agilysys' Financials

When does Agilysys's fiscal year end?

According to the most recent income statement we have on file, Agilysys' financial year ends in March. Their financial year 2024 ended on March 31, 2024.

How has Agilysys' net income changed over the last 10 years?

Agilysys' net income appears to be on an upward trend, with a most recent value of $86.20 million in 2024, rising from $17.10 million in 2014. The previous period was $14.58 million in 2023. Find out what analysts predict for Agilysys in the coming months.

What is Agilysys's operating income?

Agilysys's total operating income in 2024 was $15.75 million, based on the following breakdown:

Total Gross Profit: $144.26 million
Total Operating Expenses: $128.50 million

How has Agilysys revenue changed over the last 10 years?

Over the last 10 years, Agilysys' total revenue changed from $101.26 million in 2014 to $237.46 million in 2024, a change of 134.5%.

How much debt does Agilysys have?

Agilysys' total liabilities were at $113.95 million at the end of 2024, a 14.8% decrease from 2023, and a 96.4% increase since 2014.

How much cash does Agilysys have?

In the past 10 years, Agilysys' cash and equivalents has ranged from $39.94 million in 2018 to $144.89 million in 2024, and is currently $144.89 million as of their latest financial filing in 2024.

How has Agilysys' book value per share changed over the last 10 years?

Over the last 10 years, Agilysys' book value per share changed from 5.91 in 2014 to 9.21 in 2024, a change of 55.9%.

Related Companies

This page (NASDAQ:AGYS) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilysys (AGYS) Financials

Frequently Asked Questions About Agilysys' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agilysys (AGYS) Financials

Annual Income Statements for Agilysys

Quarterly Income Statements for Agilysys

Annual Cash Flow Statements for Agilysys

Quarterly Cash Flow Statements for Agilysys

Annual Balance Sheets for Agilysys

Quarterly Balance Sheets for Agilysys

Annual Metrics And Ratios for Agilysys

Quarterly Metrics And Ratios for Agilysys

Frequently Asked Questions About Agilysys' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools